 | • レポートコード：MRC2-11QY03925 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は無針糖尿病治療のグローバル市場について調査・分析したレポートです。種類別（インスリンパッチ、ジェットインジェクター、インスリンペン、インスリンポンプ、インスリン注入器）市場規模、用途別（消費者、診断センター、病院および診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別無針糖尿病治療の競争状況、市場シェア ・世界の無針糖尿病治療市場：種類別市場規模 2015年-2020年（インスリンパッチ、ジェットインジェクター、インスリンペン、インスリンポンプ、インスリン注入器） ・世界の無針糖尿病治療市場：種類別市場規模予測 2021年-2026年（インスリンパッチ、ジェットインジェクター、インスリンペン、インスリンポンプ、インスリン注入器） ・世界の無針糖尿病治療市場：用途別市場規模 2015年-2020年（消費者、診断センター、病院および診療所） ・世界の無針糖尿病治療市場：用途別市場規模予測 2021年-2026年（消費者、診断センター、病院および診療所） ・北米の無針糖尿病治療市場分析：米国、カナダ ・ヨーロッパの無針糖尿病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの無針糖尿病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の無針糖尿病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの無針糖尿病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Antares Pharma、European Pharma Group、Johnson and Johnson、Injex UK、Echo Therapeutics、MannKind Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic conditions, excessive excretion of urine, hunger, thirst, weight loss, fatigue and impaired vision. Diabetes is classified into Type 1 and Type 2 Diabetes.
Based on the end user, Diagnostic centers is expected to have the large market share than the others. This is because of the majorly the diabetes diagnosis tests are usually takes place in the diagnostic centers.
Market Analysis and Insights: Global Needle-Free Diabetes Care Market
The global Needle-Free Diabetes Care market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Needle-Free Diabetes Care Scope and Market Size
Needle-Free Diabetes Care market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Needle-Free Diabetes Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Antares Pharma
European Pharma Group
Johnson and Johnson
Injex UK
Echo Therapeutics
MannKind Corporation
…
Market segment by Type, the product can be split into
Insulin Patches
Jet Injectors
Insulin Pens
Insulin Pumps
Insulin Infuser
Market segment by Application, split into
Consumer
Diagnostic Centers
Hospitals and Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Needle-Free Diabetes Care Revenue
1.4 Market by Type
1.4.1 Global Needle-Free Diabetes Care Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insulin Patches
1.4.3 Jet Injectors
1.4.4 Insulin Pens
1.4.5 Insulin Pumps
1.4.6 Insulin Infuser
1.5 Market by Application
1.5.1 Global Needle-Free Diabetes Care Market Share by Application: 2020 VS 2026
1.5.2 Consumer
1.5.3 Diagnostic Centers
1.5.4 Hospitals and Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Needle-Free Diabetes Care Market Perspective (2015-2026)
2.2 Global Needle-Free Diabetes Care Growth Trends by Regions
2.2.1 Needle-Free Diabetes Care Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Needle-Free Diabetes Care Historic Market Share by Regions (2015-2020)
2.2.3 Needle-Free Diabetes Care Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Needle-Free Diabetes Care Market Growth Strategy
2.3.6 Primary Interviews with Key Needle-Free Diabetes Care Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Needle-Free Diabetes Care Players by Market Size
3.1.1 Global Top Needle-Free Diabetes Care Players by Revenue (2015-2020)
3.1.2 Global Needle-Free Diabetes Care Revenue Market Share by Players (2015-2020)
3.1.3 Global Needle-Free Diabetes Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Needle-Free Diabetes Care Market Concentration Ratio
3.2.1 Global Needle-Free Diabetes Care Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Needle-Free Diabetes Care Revenue in 2019
3.3 Needle-Free Diabetes Care Key Players Head office and Area Served
3.4 Key Players Needle-Free Diabetes Care Product Solution and Service
3.5 Date of Enter into Needle-Free Diabetes Care Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Needle-Free Diabetes Care Historic Market Size by Type (2015-2020)
4.2 Global Needle-Free Diabetes Care Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Needle-Free Diabetes Care Market Size by Application (2015-2020)
5.2 Global Needle-Free Diabetes Care Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Needle-Free Diabetes Care Market Size (2015-2020)
6.2 Needle-Free Diabetes Care Key Players in North America (2019-2020)
6.3 North America Needle-Free Diabetes Care Market Size by Type (2015-2020)
6.4 North America Needle-Free Diabetes Care Market Size by Application (2015-2020)
7 Europe
7.1 Europe Needle-Free Diabetes Care Market Size (2015-2020)
7.2 Needle-Free Diabetes Care Key Players in Europe (2019-2020)
7.3 Europe Needle-Free Diabetes Care Market Size by Type (2015-2020)
7.4 Europe Needle-Free Diabetes Care Market Size by Application (2015-2020)
8 China
8.1 China Needle-Free Diabetes Care Market Size (2015-2020)
8.2 Needle-Free Diabetes Care Key Players in China (2019-2020)
8.3 China Needle-Free Diabetes Care Market Size by Type (2015-2020)
8.4 China Needle-Free Diabetes Care Market Size by Application (2015-2020)
9 Japan
9.1 Japan Needle-Free Diabetes Care Market Size (2015-2020)
9.2 Needle-Free Diabetes Care Key Players in Japan (2019-2020)
9.3 Japan Needle-Free Diabetes Care Market Size by Type (2015-2020)
9.4 Japan Needle-Free Diabetes Care Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Needle-Free Diabetes Care Market Size (2015-2020)
10.2 Needle-Free Diabetes Care Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Needle-Free Diabetes Care Market Size by Type (2015-2020)
10.4 Southeast Asia Needle-Free Diabetes Care Market Size by Application (2015-2020)
11 India
11.1 India Needle-Free Diabetes Care Market Size (2015-2020)
11.2 Needle-Free Diabetes Care Key Players in India (2019-2020)
11.3 India Needle-Free Diabetes Care Market Size by Type (2015-2020)
11.4 India Needle-Free Diabetes Care Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Needle-Free Diabetes Care Market Size (2015-2020)
12.2 Needle-Free Diabetes Care Key Players in Central & South America (2019-2020)
12.3 Central & South America Needle-Free Diabetes Care Market Size by Type (2015-2020)
12.4 Central & South America Needle-Free Diabetes Care Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Antares Pharma
13.1.1 Antares Pharma Company Details
13.1.2 Antares Pharma Business Overview
13.1.3 Antares Pharma Needle-Free Diabetes Care Introduction
13.1.4 Antares Pharma Revenue in Needle-Free Diabetes Care Business (2015-2020))
13.1.5 Antares Pharma Recent Development
13.2 European Pharma Group
13.2.1 European Pharma Group Company Details
13.2.2 European Pharma Group Business Overview
13.2.3 European Pharma Group Needle-Free Diabetes Care Introduction
13.2.4 European Pharma Group Revenue in Needle-Free Diabetes Care Business (2015-2020)
13.2.5 European Pharma Group Recent Development
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Details
13.3.2 Johnson and Johnson Business Overview
13.3.3 Johnson and Johnson Needle-Free Diabetes Care Introduction
13.3.4 Johnson and Johnson Revenue in Needle-Free Diabetes Care Business (2015-2020)
13.3.5 Johnson and Johnson Recent Development
13.4 Injex UK
13.4.1 Injex UK Company Details
13.4.2 Injex UK Business Overview
13.4.3 Injex UK Needle-Free Diabetes Care Introduction
13.4.4 Injex UK Revenue in Needle-Free Diabetes Care Business (2015-2020)
13.4.5 Injex UK Recent Development
13.5 Echo Therapeutics
13.5.1 Echo Therapeutics Company Details
13.5.2 Echo Therapeutics Business Overview
13.5.3 Echo Therapeutics Needle-Free Diabetes Care Introduction
13.5.4 Echo Therapeutics Revenue in Needle-Free Diabetes Care Business (2015-2020)
13.5.5 Echo Therapeutics Recent Development
13.6 MannKind Corporation
13.6.1 MannKind Corporation Company Details
13.6.2 MannKind Corporation Business Overview
13.6.3 MannKind Corporation Needle-Free Diabetes Care Introduction
13.6.4 MannKind Corporation Revenue in Needle-Free Diabetes Care Business (2015-2020)
13.6.5 MannKind Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Needle-Free Diabetes Care Key Market Segments
Table 2. Key Players Covered: Ranking by Needle-Free Diabetes Care Revenue
Table 3. Ranking of Global Top Needle-Free Diabetes Care Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Needle-Free Diabetes Care Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insulin Patches
Table 6. Key Players of Jet Injectors
Table 7. Key Players of Insulin Pens
Table 8. Key Players of Insulin Pumps
Table 9. Key Players of Insulin Infuser
Table 10. Global Needle-Free Diabetes Care Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Needle-Free Diabetes Care Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Needle-Free Diabetes Care Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Needle-Free Diabetes Care Market Share by Regions (2015-2020)
Table 14. Global Needle-Free Diabetes Care Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Needle-Free Diabetes Care Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Needle-Free Diabetes Care Market Growth Strategy
Table 20. Main Points Interviewed from Key Needle-Free Diabetes Care Players
Table 21. Global Needle-Free Diabetes Care Revenue by Players (2015-2020) (Million US$)
Table 22. Global Needle-Free Diabetes Care Market Share by Players (2015-2020)
Table 23. Global Top Needle-Free Diabetes Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Diabetes Care as of 2019)
Table 24. Global Needle-Free Diabetes Care by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Needle-Free Diabetes Care Product Solution and Service
Table 27. Date of Enter into Needle-Free Diabetes Care Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 30. Global Needle-Free Diabetes Care Market Size Share by Type (2015-2020)
Table 31. Global Needle-Free Diabetes Care Revenue Market Share by Type (2021-2026)
Table 32. Global Needle-Free Diabetes Care Market Size Share by Application (2015-2020)
Table 33. Global Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 34. Global Needle-Free Diabetes Care Market Size Share by Application (2021-2026)
Table 35. North America Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 37. North America Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 38. North America Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 39. North America Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 40. North America Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 41. Europe Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 43. Europe Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 45. Europe Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 47. China Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 48. China Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 49. China Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 50. China Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 51. China Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 52. China Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 53. Japan Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 55. Japan Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 57. Japan Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 61. Southeast Asia Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 63. Southeast Asia Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 65. India Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 66. India Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 67. India Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 68. India Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 69. India Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 70. India Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Needle-Free Diabetes Care Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Needle-Free Diabetes Care Market Share (2019-2020)
Table 73. Central & South America Needle-Free Diabetes Care Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Needle-Free Diabetes Care Market Share by Type (2015-2020)
Table 75. Central & South America Needle-Free Diabetes Care Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Needle-Free Diabetes Care Market Share by Application (2015-2020)
Table 77. Antares Pharma Company Details
Table 78. Antares Pharma Business Overview
Table 79. Antares Pharma Product
Table 80. Antares Pharma Revenue in Needle-Free Diabetes Care Business (2015-2020) (Million US$)
Table 81. Antares Pharma Recent Development
Table 82. European Pharma Group Company Details
Table 83. European Pharma Group Business Overview
Table 84. European Pharma Group Product
Table 85. European Pharma Group Revenue in Needle-Free Diabetes Care Business (2015-2020) (Million US$)
Table 86. European Pharma Group Recent Development
Table 87. Johnson and Johnson Company Details
Table 88. Johnson and Johnson Business Overview
Table 89. Johnson and Johnson Product
Table 90. Johnson and Johnson Revenue in Needle-Free Diabetes Care Business (2015-2020) (Million US$)
Table 91. Johnson and Johnson Recent Development
Table 92. Injex UK Company Details
Table 93. Injex UK Business Overview
Table 94. Injex UK Product
Table 95. Injex UK Revenue in Needle-Free Diabetes Care Business (2015-2020) (Million US$)
Table 96. Injex UK Recent Development
Table 97. Echo Therapeutics Company Details
Table 98. Echo Therapeutics Business Overview
Table 99. Echo Therapeutics Product
Table 100. Echo Therapeutics Revenue in Needle-Free Diabetes Care Business (2015-2020) (Million US$)
Table 101. Echo Therapeutics Recent Development
Table 102. MannKind Corporation Company Details
Table 103. MannKind Corporation Business Overview
Table 104. MannKind Corporation Product
Table 105. MannKind Corporation Revenue in Needle-Free Diabetes Care Business (2015-2020) (Million US$)
Table 106. MannKind Corporation Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Needle-Free Diabetes Care Market Share by Type: 2020 VS 2026
Figure 2. Insulin Patches Features
Figure 3. Jet Injectors Features
Figure 4. Insulin Pens Features
Figure 5. Insulin Pumps Features
Figure 6. Insulin Infuser Features
Figure 7. Global Needle-Free Diabetes Care Market Share by Application: 2020 VS 2026
Figure 8. Consumer Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Needle-Free Diabetes Care Report Years Considered
Figure 12. Global Needle-Free Diabetes Care Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Needle-Free Diabetes Care Market Share by Regions: 2020 VS 2026
Figure 14. Global Needle-Free Diabetes Care Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Needle-Free Diabetes Care Market Share by Players in 2019
Figure 17. Global Top Needle-Free Diabetes Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Diabetes Care as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Needle-Free Diabetes Care Revenue in 2019
Figure 19. North America Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Needle-Free Diabetes Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
インスリンペン針の世界市場（～2026年） Market Analysis and Insights: Global Insulin Pen Needle Market The global Insulin Pen Needle market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Pen Needle Scope and Market Size Insulin Pen Needle market is segment…- 無針注射システムの世界市場（～2026年） Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle. Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needl…
- 無針ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Needle-Free Drug Delivery Market The global Needle-Free Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Needle-Free Drug Delivery Scope and Market Size Needle-Free Dru…
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…
- 糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…